In today’s competitive job market, resumes that highlight measurable achievements stand out far more than those listing generic duties. By combining clear metrics, ATS-friendly formatting, and a ...

Apotex Inc. has won tentative approval from the U.S. Food and Drug Administration for a cheaper, generic form of Ozempic six years before the patent expires there, while no generic versions have been ...

Generic dapagliflozin is indicated for adults with type 2 diabetes and to reduce heart failure hospitalization risk in adults with T2D and established cardiovascular disease. The Food and Drug ...

Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established cardiovascular disease or multiple risk factors, and to improve glycemic control ...

Abstract: The timetabling problem, a well-known NP-Hard optimization challenge, spans multiple domains such as education, healthcare, sports, and transportation. Due to its computational complexity, ...

Jon McNeill, a serial founder, was the president of sales at Tesla from 2015 to 2018. At Tesla, McNeill helped develop a five-step framework that he says brought innovation to Tesla. The five-step ...

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...

To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Nearly half of U.S. generic prescriptions originate in India, which relies on the Strait of ...